» Articles » PMID: 36355500

The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases

Overview
Publisher MDPI
Specialty Chemistry
Date 2022 Nov 10
PMID 36355500
Authors
Affiliations
Soon will be listed here.
Abstract

Plant polysaccharides (PPS) composed of more than 10 monosaccharides show high safety and various pharmacological activities, including immunoregulatory, antitumor, antioxidative, antiaging, and other effects. In recent years, emerging evidence has indicated that many PPS are beneficial for metabolic diseases, such as cardiovascular disease (CVD), diabetes, obesity, and neurological diseases, which are usually caused by the metabolic disorder of fat, sugar, and protein. In this review, we introduce the common characteristics and functional activity of many representative PPS, emphasize the common risks and molecular mechanism of metabolic diseases, and discuss the pharmacological activity and mechanism of action of representative PPS obtained from plants including , , pumpkin, , , , , , and tea in metabolic diseases. Finally, this review will provide directions and a reference for future research and for the development of PPS into potential drugs for the treatment of metabolic diseases.

Citing Articles

Green Sulfation of Arabinogalactan in the Melt of a Sulfamic Acid-Urea Mixture.

Levdansky V, Levdansky A, Malyar Y, Ivanenko T, Fetisova O, Kazachenko A Polymers (Basel). 2025; 17(5).

PMID: 40076134 PMC: 11902456. DOI: 10.3390/polym17050642.


The effects of fermented polysaccharides on the growth performance, antioxidant capacity and intestinal health of broilers.

Liu Z, Zhang H, Chen X, Yu W, Li S, Kang L Front Vet Sci. 2025; 12:1530117.

PMID: 40070915 PMC: 11894608. DOI: 10.3389/fvets.2025.1530117.


Harnessing the FOXO-SIRT1 axis: insights into cellular stress, metabolism, and aging.

Gupta S, Afzal M, Agrawal N, Almalki W, Rana M, Gangola S Biogerontology. 2025; 26(2):65.

PMID: 40011269 DOI: 10.1007/s10522-025-10207-0.


Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach.

Imran M, Altamimi A, Afzal M, Babu M, Goyal K, Ballal S Biogerontology. 2025; 26(1):45.

PMID: 39831933 DOI: 10.1007/s10522-025-10189-z.


Forecasting cardiovascular disease mortality using artificial neural networks in Sindh, Pakistan.

Qureshi M, Ishaq K, Daniyal M, Iftikhar H, Rehman M, Salar S BMC Public Health. 2025; 25(1):34.

PMID: 39754102 PMC: 11699765. DOI: 10.1186/s12889-024-21187-0.


References
1.
Fan Y, Zhou X, Huang G . Preparation, structure, and properties of tea polysaccharide. Chem Biol Drug Des. 2021; 99(1):75-82. DOI: 10.1111/cbdd.13924. View

2.
Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

3.
Kassi E, Pervanidou P, Kaltsas G, Chrousos G . Metabolic syndrome: definitions and controversies. BMC Med. 2011; 9:48. PMC: 3115896. DOI: 10.1186/1741-7015-9-48. View

4.
Wang Q, Yang X, Zhu C, Liu G, Sun Y, Qian L . Advances in the Utilization of Tea Polysaccharides: Preparation, Physicochemical Properties, and Health Benefits. Polymers (Basel). 2022; 14(14). PMC: 9320580. DOI: 10.3390/polym14142775. View

5.
Liu G, Liang L, Yu G, Li Q . Pumpkin polysaccharide modifies the gut microbiota during alleviation of type 2 diabetes in rats. Int J Biol Macromol. 2018; 115:711-717. DOI: 10.1016/j.ijbiomac.2018.04.127. View